Abstract:Objective To evaluate the value of transrectal ultrasound-guided systematic prostate biopsy and magnetic resonance imaging(MRI) suspicious targeted biopsy in the biopsy of prostate cancer.Methods A retrospective analysis was performed in 181 patients with suspected prostate cancer underwent transrectal ultrasound-guided prostate biopsy from September 2011 to September 2013 in the Second Affiliated Hospital of Zhejiang University School of Medicine.In all the 181 patients had the transrectal ultrasound-guided systematic biopsy,116 patients with suspicious MRI had two additional targeted biopsies.Prostate cancers were detected in 97 of 181 patients,and the prostatic hyperplasia were detected in 84 patients.The detection rate of transrectal ultrasound-guided systematic prostate biopsy,suspicious MRI targeted biopsy and combined biopsy in prostate cancer were tested by χ2 test.Compared with pathological results,the sensitivity,specificity,accuracy,positive predictive value and negative predictive value of transrectal ultrasound-guided systematic prostate biopsy and suspicious MRI targeted biopsy were calculated and tested by χ2 test.Results Prostate cancer was detected in 97 of 181 patients(53.6%),63(34.8%) was detected by transrectal ultrasound-guided systematic prostate biopsy,and 81(44.8%) was detected by suspicious MRI targeted biopsy.The suspicious MRI targeted biopsy detected more prostate cancers which there had statistical differences compared with transrectal ultrasound-guided systematic prostate biopsy(χ2=34.830,P=0.015).Transrectal ultrasound guided prostate systematic biopsy missed 34 cases of prostate cancer,and suspicious MRI targeted biopsy missed 16 cases,accounting for 35.1%(34/97) and 16.5%(16/97) of prostate cancer.The 181 patients were biopsied a total of 1 896 cores,including transrectal ultrasound guided systematic biopsy 1 448 cores and suspicious MRI targeted biopsy 448 cores.The sensitivity,specifi city,positive predictive value and negative predictive value of suspicious MRI targeted biopsy was 89.8%(280/312),87.4%(1 384/1 584),58.3%(280/480),97.7%(1 384/1 416) compared with the sensitivity of 71.8%(224/312),specifi city of 22.7%(360/1 584),positive predictive value of 15.5%(224/1 448) and negative predictive value of 80.4%(360/448) in transrectal ultrasound-guided systematic prostate biopsy(χ2=14.008,96.037,143.049,170.729,all P < 0.001).Conclusions The detection rate of prostate cancer of suspicious MRI targeted biopsy is higher than transrectal ultrasound-guided systematic prostate biopsy,but can′t replace transrectal ultrasound-guided systematic prostate biopsy.The two methods are complementary to improve the prostate cancer detection rate.

The guiding value of multi-sequence MRI in performing biopsy and repeated biopsy of the prostate cancer

The value of transrectal ultrasound-guided systematic prostate biopsy and additional targeted cores from suspicious magnetic resonance imaging in the biopsy of prostate cancer

Real-time precision targeted prostate biopsy using transrectal ultrasound-magnetic resonance fusion

PREDICTION OF PROSTATE BIOPSY OUTCOME BY MULTIPARAMETRIC ULTRASOUND IMAGING

The Value Analysis in the Diagnosis of Nonspecific Granulomatous Prostatitis by Transrectal Ultrasound Guided Biopsies

Value of synthetic MRI quantitative parameters in preprocedural evaluation for TRUS/MRI fusion‐guided biopsy of the prostate

Application value of multi-parameter magnetic resonance image-transrectal ultrasound cognitive fusion in prostate biopsy

MR Diffusion Weighted Imaging and TRUS Jointly Guided Transperineal Prostate Biopsy(Report of 90 Cases)

Biopsy strategies in the era of mpMRI: a comprehensive review

Interpretation of the IP1-PROSTAGRAM study of magnetic resonance or ultrasound for screening men with prostate cancer

MRI/US imaging fusion guided transperineal prostate biopsy:a research in single center

Targeted Biopsy with MRI and Ultrasound Improves Detection of High Risk Prostate Cancer

Computer-aided detection of prostate cancer in early stages using multi-parameter MRI: A promising approach for early diagnosis

MRI–Ultrasound Fused Approach for Prostate Biopsy—How It Is Performed

Accuracy of MRI-ultrasound fusion-guided and systematic biopsy of the prostate

Magnetic Resonance Imaging Guided Prostate Biopsy in Patients with ≥ One Negative Systematic Transrectal Ultrasound-Guided Biopsy: A Systemic Review and Meta-Analysis

[The Value of Diffusion-Weighted MR Imaging Combined with Transrectal Ultrasound for Transrectal Prostate Biopsy].

Evaluating Prostate Cancer: The Diagnostic Impact of MRI and Its Relationship With Transrectal Ultrasound (TRUS)-Guided Biopsy

Evaluation of multiparametric MRI in predicting seminal vesicle invasion of prostate cancer

A fusion system of transrectal ultrasound with magnetic resonance imaging in guidance of prostate cancer biopsy

Value of cognitive fusion targeted and standard systematic transrectal prostate biopsy for prostate cancer diagnosis